News

First oral drug shows promise for Barth syndrome heart and muscle symptoms
Researchers at Tohoku University have discovered that an oral drug called MA-5 can improve both heart and muscle problems in ...
News-Medical.Net15h
Oral drug MA-5 can improve heart and muscle problems in Barth syndrome
Researchers at Tohoku University have discovered that an oral drug called MA-5 can improve both heart and muscle problems in ...
Neurons duped into delivering mitochondria to cancer cells found fueling tumor spread
University of South Alabama researchers report that neurons can transfer mitochondria directly to cancer cells, enhancing ...
Chinese scientists develop gene-editing tool to treat incurable diseases
Their method is the first to directly fix flaws in animals’ mitochondrial DNA, which are responsible for severe and deadly conditions.
Thiogenesis Receives Confirmatory Guidance on IMPD for Pediatric MASH Phase 2a Clinical Trial in Europe and Core Patent Granted in EU
June 25, 2025) - Thiogenesis Therapeutics, Inc. (TSXV: TTI) (OTCQX: TTIPF), a clinical-stage biopharmaceutical company developing next-generation thiol-based therapies for mitochondrial disease and ...